PHIO PHARMACEUTICALS CORP. Proceeds from Issuance of Redeemable Preferred Stock
PHIO PHARMACEUTICALS CORP. (PHIO) reported Proceeds from Issuance of Redeemable Preferred Stock of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock · last filed 2024-04-01
- PHIO PHARMACEUTICALS CORP. proceeds from issuance of redeemable preferred stock for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- PHIO PHARMACEUTICALS CORP. proceeds from issuance of redeemable preferred stock for fiscal 2022 was $2.00K.
- PHIO PHARMACEUTICALS CORP. proceeds from issuance of redeemable preferred stock for fiscal 2021 was $0.00.
| Period end | Proceeds from Issuance of Redeemable Preferred Stock 12 month |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 |
| 2022-12-31 | $2.00K 10-K · filed 2024-04-01 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |